β-Amyloid-Induced Inflammation and Cholinergic Hypofunction in the Rat Brain in Vivo: Involvement of the p38MAPK Pathway

Cited by papers we hold 10

• Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes · 2022
  No notice
• Insulin and Insulin Resistance in Alzheimer’s Disease · 2021
  No notice
• Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease · 2017
  No notice
• Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease · 2012
  No notice
• The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease · 2012
  No notice
• Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia · 2009
  No notice
• Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation · 2008
  No notice
• Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid · 2008
  No notice
• A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model · 2007
  No notice
• Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.